APA (7th ed.) Citation

Trojano, M., Paolicelli, D., Fuiani, A., Pellegrini, F., Iaffaldano, P., Direnzo, V., & D’Onghia, M. (2008). Postmarketing evidence of disease-modifying drugs in multiple sclerosis. Neurological Sciences: Official Journal of the Italian Neurological Society, 29(2), 225. https://doi.org/10.1007/s10072-008-0944-z

Chicago Style (17th ed.) Citation

Trojano, Maria, Damiano Paolicelli, Aurora Fuiani, Fabio Pellegrini, Pietro Iaffaldano, Vita Direnzo, and Mariangela D’Onghia. "Postmarketing Evidence of Disease-modifying Drugs in Multiple Sclerosis." Neurological Sciences: Official Journal of the Italian Neurological Society 29, no. 2 (2008): 225. https://doi.org/10.1007/s10072-008-0944-z.

MLA (9th ed.) Citation

Trojano, Maria, et al. "Postmarketing Evidence of Disease-modifying Drugs in Multiple Sclerosis." Neurological Sciences: Official Journal of the Italian Neurological Society, vol. 29, no. 2, 2008, p. 225, https://doi.org/10.1007/s10072-008-0944-z.